Grant: Canada-UK Joint Health Research Program on Antibiotic Resistance
University of Guelph
$60,000.00
UKCan-BaCWAN: A bilateral bacterial cell wall biosynthesis network
FY 2008-09
Summary
A number of strong academic laboratories that focus on the different elements of bacterial cell wall metabolism are widely scattered across both Canada and the UK. To consolidate this expertise and ensure the best possible synergy, we propose to create a bilateral network, called the UK-Canadian Bacterial Cell Wall Biosynthesis Network (UkCan-BaCWAN). Its mission will be to provide a forum for academic, government and industrial researchers to meet and initiate collaborative ventures aimed at a further understanding of the biology of bacterial cell wall biosynthesis and the development of novel antibiotics and antimicrobial strategies. It will be organized and structured to provide complimentary expertise and services including, synthetic organic chemistry, x-ray crystallographic analysis of proteins, and the high throughput screening for small molecule inhibitors. Members are recognized internationally for their work on: 1) enzymes associated with peptidoglycan metabolism and lysis, antibiotic resistance and efflux; 2) the development of antibiotics associated with cell wall targets ; 3) cell wall metabolism and antibiotic efficacy in biofilms; 4)investigating the potential for immunomodulatory and/or adjuvant strategies, and 5) phage-induced cell wall lysis. The enhanced synergy obtained by the creation of the UkCan network would provide the potential to achieve the highest impact in identifying new targets in cell wall biosynthesis, refining the development of current antibiotics and inhibitors, screening for new antimicrobial compounds, and investigating novel strategies for combating bacterial infections, including phage therapy. This will be accomplished through the organization of two workshop/conferences, one on each side of the Atlantic, where respective members would develop appropriate research strategies, develop plans for collaborative investigations, and develop joint research proposals.
Department
Program
Canada-UK Joint Health Research Program on Antibiotic Resistance
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
182401
Name
Clarke Anthony J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Medical Research Council (UK)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Special Cases
Projecttitle
UKCan-BaCWAN: A bilateral bacterial cell wall biosynthesis network
Programtype2
Operating Grants
Orgnameinp2
University of Guelph
Cihramount2
$60,000
Cihrequipment2
$0
Programname2
Canada-UK Joint Health Research Program on Antibiotic Resistance
Keyworddelim
Antibiotic Resistance; Autolysins; Novel Antibiotic Targets; Novel Antibiotics; Peptidoglycan Metabolism; Phage Therapy
Abstract
A number of strong academic laboratories that focus on the different elements of bacterial cell wall metabolism are widely scattered across both Canada and the UK. To consolidate this expertise and ensure the best possible synergy, we propose to create a bilateral network, called the UK-Canadian Bacterial Cell Wall Biosynthesis Network (UkCan-BaCWAN). Its mission will be to provide a forum for academic, government and industrial researchers to meet and initiate collaborative ventures aimed at a further understanding of the biology of bacterial cell wall biosynthesis and the development of novel antibiotics and antimicrobial strategies. It will be organized and structured to provide complimentary expertise and services including, synthetic organic chemistry, x-ray crystallographic analysis of proteins, and the high throughput screening for small molecule inhibitors. Members are recognized internationally for their work on: 1) enzymes associated with peptidoglycan metabolism and lysis, antibiotic resistance and efflux; 2) the development of antibiotics associated with cell wall targets ; 3) cell wall metabolism and antibiotic efficacy in biofilms; 4)investigating the potential for immunomodulatory and/or adjuvant strategies, and 5) phage-induced cell wall lysis. The enhanced synergy obtained by the creation of the UkCan network would provide the potential to achieve the highest impact in identifying new targets in cell wall biosynthesis, refining the development of current antibiotics and inhibitors, screening for new antimicrobial compounds, and investigating novel strategies for combating bacterial infections, including phage therapy. This will be accomplished through the organization of two workshop/conferences, one on each side of the Atlantic, where respective members would develop appropriate research strategies, develop plans for collaborative investigations, and develop joint research proposals.
Competitiondate
200903
Approvedterm2
0 yr 9 mths
Pinamesdelim
Clarke, Anthony J; Dowson, Christopher G
Approvedterm
0 an 9 mois
Cihrcontribution2
Inst of Infection & Immunity~ $60,000~ $0~